National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 99,646 cases where Vaccine targets Shingles (VARZOS) and Submission Date on/before '2018-05-31'

Government Disclaimer on use of this data



Case Details

This is page 9 out of 9,965

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next


VAERS ID: 267063 (history)  
Form: Version 1.0  
Age: 64.0  
Sex: Female  
Location: California  
Vaccinated:2006-10-04
Onset:2006-10-04
   Days after vaccination:0
Submitted: 2006-11-14
   Days after onset:41
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0981F / UNK - / SC

Administered by: Other       Purchased by: Other
Symptoms: Cardiac disorder, Electrocardiogram abnormal, Palpitations
SMQs:, Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Atenolol, Carisoprodol (Soma), Estrace, Cytotec, Lodine, Pamelor.
Current Illness:
Preexisting Conditions: Nausea, Rheumatoid arthritis, allergic reaction to antibiotics.
Allergies:
Diagnostic Lab Data: Electrocardiogram 10/09/06 Frequent PVCs
CDC Split Type: WAES0610USA08374

Write-up: Information has been received from a physician concerning a 64 year old female with rheumatoid arthritis and allergic reaction to Erythromycin (nausea) who on 10/04/06 was vaccinated with a dose of varicella zoster vaccine (lot 652936/0981F). The physician reported that the pt received a 0.5ml dose. Concomitant therapy included Atenolol, Carisoprodol (Soma), Estrace, Cytotec, Lodine, Pamelor. Subsequently on 10/04/06, the pt experienced increased heart palpitations. The pt was seen for follow up on 10/9/06, the palpitations were persisting and the pt had frequent PVC on EKG. Prescription drug treatment was required, the pts Atenolol was increased. At the time of the report, the pt had not recovered. No quality complaint was involved. Additional information has been requested.


VAERS ID: 267064 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Alabama  
Vaccinated:2006-10-09
Onset:2006-10-12
   Days after vaccination:3
Submitted: 2006-11-14
   Days after onset:33
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Erythema, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA09283

Write-up: Information has been received from a physician concerning a female who on 10/09/06 was vaccinated with a 0.65 ml dose of Varicella Zoster vaccine. On 10/12/06 the pt experienced red rashes on both arms similar to poison ivy or oak. It was reported that the pt has not been near either plant. No other vaccinations were administered. Unspecified medication attention was sought. At the time of the report, the pt had not recovered. No product quality complaint was involved. Additional information has been requested.


VAERS ID: 267065 (history)  
Form: Version 1.0  
Age: 84.0  
Sex: Female  
Location: California  
Vaccinated:2006-10-13
Onset:2006-10-13
   Days after vaccination:0
Submitted: 2006-11-14
   Days after onset:32
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / UNK - / SC

Administered by: Other       Purchased by: Other
Symptoms: Dermatitis, Flushing
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: albuterol, ATROVENT, COZAAR, nifedipine
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA09750

Write-up: Information has been received from a physician concerning an 84 year old white female who on 13-OCT-2006 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX. Concomitant therapy included nifedipine, losartan potassium (MSD), albuterol and ipratropium bromide (ATROVENT). On 13-OCT-2006 within minutes to hours of the injection the patient experienced flushing and transient dermatitis on the face, arms and legs. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested. 6/17/10 Additional information has been received by the physician indicating that the "reaction turned out to be from taking NIACIN, which the patient bought by accident instead of THIAMINE". No further information was reported.


VAERS ID: 267066 (history)  
Form: Version 1.0  
Age: 72.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2006-10-16
Onset:2006-10-17
   Days after vaccination:1
Submitted: 2006-11-14
   Days after onset:28
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0981F / UNK RA / SC

Administered by: Other       Purchased by: Other
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: EVISTA
Current Illness:
Preexisting Conditions: Penicillin allergy, sulfonamide allergy, drug hypersensitivity
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type: WAES0610USA11157

Write-up: Information has been received from a physician concerning a 72 year old female with allergies to penicillin, sulfa, tetracycline, and prochlorperazine maleate (COMPAZINE) and no other medical history who on 16-OCT-2006 was vaccinated SC in the right arm with a dose of ZOSTAVAX (lot #652936/0981F). Concomitant therapy included raloxifene hydrochloride (EVISTA). On 17-OCT-2006 the patient developed a welt at the site of injection. The site of injection was swollen, red, and itchy. The physician stated that the patient had an appointment to be examined on 18-OCT-2006. The patient was currently taking topical hydrocortisone cream and would be advised to take diphenhydramine. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.


VAERS ID: 267067 (history)  
Form: Version 1.0  
Age: 72.0  
Sex: Female  
Location: Colorado  
Vaccinated:2006-08-30
Onset:2006-08-30
   Days after vaccination:0
Submitted: 2006-11-14
   Days after onset:76
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 RA / SC

Administered by: Private       Purchased by: Private
Symptoms: Injection site erythema, Injection site hypersensitivity, Pruritus
SMQs:, Anaphylactic reaction (broad), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CELEBREX, hydrochlorothiazide, ZESTRIL, CLARITIN, lovastatin, tamoxifen citrate, verapamil
Current Illness: Blood pressure high; Allergic reaction to antibiotics; Drug hypersensitivity; Sulfonamide allergy; Cholesterol high
Preexisting Conditions: Kidney stone; Breast cancer
Allergies:
Diagnostic Lab Data: NONE body temp, 08/30/06, afebrile
CDC Split Type: WAES0610USA11295

Write-up: This is in follow-up to report(s) previously submitted on 11/14/2006. Information has been received from a healthcare worker concerning a 72 year old female breast cancer survivor with high blood pressure, high cholesterol, sulfonamide allergy and streptomycin and NORFLEX allergies and a history of kidney stone and on 30-AUG-2006 at 14:00 PM was vaccinated SC in the right arm with a 0.65 mL first dose of ZOSTAVAX (Merck) (lot # 652965/0622F). Concomitant therapy included celecoxib (CELEBREX), lisinopril (ZESTRIL), hydrochlorothiazide (manufacturer unknown), lovastatin, verapamil, tamoxifen citrate, and loratadine (CLARITIN). There was no illness at the time of vaccination. On 30-AUG-2006, the patient developed a "very large spot that was red, raised and itchy." No fever was noted. The patient took diphenhydramine hydrochloride (BENADRYL), but the spot was still present at the injection site as of 30-OCT-2006. The spot was smaller, but still present. The patient did not seek medical attention and no diagnostic laboratory tests were performed. The patient has no known adverse events following prior vaccination. There was no product quality complaint involved. Additional information has been requested. Additional information has been received from the healthcare worker who reported that the immediately after the patient''s immunization, in the early evening of 30-AUG-2006, the site was softball-sized and interfered with her sleep. One month later, her injection site was still itchy, red, and raised. The patient recovered in October 2006. No further information is expected.


VAERS ID: 267068 (history)  
Form: Version 1.0  
Age: 61.0  
Sex: Female  
Location: New York  
Vaccinated:2006-10-18
Onset:2006-10-19
   Days after vaccination:1
Submitted: 2006-11-14
   Days after onset:26
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PPV: PNEUMO (PNEUMOVAX) / MERCK & CO. INC. 1036P / 1 UN / IM
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0621F / 1 LA / SC

Administered by: Other       Purchased by: Other
Symptoms: Body temperature, Herpes zoster, Injection site rash, Pain, Rash pruritic, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Drug hypersensitivity; Hypertension; General symptom
Preexisting Conditions: Chickenpox
Allergies:
Diagnostic Lab Data: body temp, 10/20/06, maximum temperature 99.6
CDC Split Type: WAES0610USA12072

Write-up: Information has been received from a physician and a licensed practical nurse concerning a 61 year old patient with allergies to codeine and nalbuphine hydrochloride (NUBAIN) and not other medical history who on 18-OCT-2006 was vaccinated SC with a 0.65 mL dose of ZOSTAVAX. Concomitant vaccination on the same day included a dose of PNEUMOVAX 23. On 19-OCT-2006, the patient presented with a zoster rash. The nurse reported that the patient had an injection site reaction that looked like shingles which was painful and itchy. The rash looked like hives, but was not blistery. The rash spread from the injection site in the left arm to her chest. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 11/14/2006. Information has been received from a physician and a licensed practical nurse concerning a 61 year old female patient with allergies to codeine and NUBAIN and no other medical history who on 18-OCT-2006 was vaccinated SC in the left arm with ZOSTAVAX (Merck) (lot # 652925/0621F). Concomitant vaccination on the same day included a dose of PNEUMOVAX. On 19-OCT-2006, the patient presented with a zoster rash. The nurse reported that the patient had an injection site reaction that looked like shingles which was painful and itchy. The rash looked lik hives, but was not blistery. The rash spread from the injection site in the left arm to her chest. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information indicated that on 20-OCT-2006 the patient developed possible herpes zoster which was described as mutiple, red, indurated patches over the left deltoid 1-3 cm in size. Her maximum temperature was 99.6 pain was rated as 5 (on a scale of 0-10) and other systemic symptoms included malaise and myalgias. Subsequently the patient recovered. It was reported that the patient had a history childhood chickenpox. No recent exposure to chickenpox or herpes zoster was reported. No further information is available.


VAERS ID: 267069 (history)  
Form: Version 1.0  
Age: 89.0  
Sex: Female  
Location: Michigan  
Vaccinated:2006-10-09
Onset:2006-10-10
   Days after vaccination:1
Submitted: 2006-11-14
   Days after onset:35
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / SC

Administered by: Private       Purchased by: Private
Symptoms: Abdominal pain upper, Asthenia, Dizziness, Feeling hot, Glossodynia, Headache, Hypokinesia, Myalgia, Neck pain, Pain, Paraesthesia oral, Sensation of pressure
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Cholesterol high; blood pressure high; osteopenia
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA12613

Write-up: Information has been received from a physician concerning an 89 year old female with high cholesterol, high blood pressure and osteopenia who on 09-OCT-2006 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX. Concomitant vaccination included a dose of influenza virus vaccine (unspecified) on 05-OCT-2006. In the morning of 10-OCT-2006 the patient experienced excruciating body pain, burning and throbbing of ears, pressure in head, stomach pain, severe headache and was lightheaded. She had achiness and tightness with sore muscles of the neck, shoulders and arms. Her entire body was weak, she was unable to turn her head. She also had burning in mouth and tongue. Unspecified medical attention was sought. The patient had improvement, but was not fully recovered. There was no product quality complaint involved. Additional information has been requested.


VAERS ID: 267070 (history)  
Form: Version 1.0  
Age: 73.0  
Sex: Female  
Location: Florida  
Vaccinated:2006-10-05
Onset:0000-00-00
Submitted: 2006-11-14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: Shingles, sulfonamide allergy
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type: WAES0610USA12879

Write-up: Information has been received from a 73 year old female consumer with a sulfonamide allergy and a history of shingles who on 05-OCT-2006 was vaccinated with a dose of ZOSTAVAX. There was no concomitant medication. Subsequently "a few days" after getting the vaccine she developed a "really bad rash." As of 24-OCT-2006 the patient had not recovered. Medical attention was sought. There was no product quality complaint involved. Additional information has been requested.


VAERS ID: 267071 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: California  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2006-11-14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HBHEPB: HIB + HEP B (COMVAX) / MERCK & CO. INC. - / UNK UN / UN
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Medication error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA13532

Write-up: Information has been received from a physician concerning a patient who was vaccinated with one dose of ZOSTAVAX. The physician reported that the vaccine was administered using COMVAX as a diluent. The reporter had not heard of any reaction to this. A product quality complaint was not involved. Additional information has been requested.


VAERS ID: 267072 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Pennsylvania  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2006-11-14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Herpes zoster, Viral infection
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA13950

Write-up: Information has been received from a physician concerning a pt who on an unspecified date was vaccainted with a dose of Varicella vaccine. Subsequently the pt developed shingles after getting the vaccine. No further information has been available. Additional information has been requested.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=9&VAX=VARZOS&VAXTYPES=Shingles&SUB_YEAR_HIGH=2018&SUB_MONTH_HIGH=05


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166